Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial. - Bradbury CA; McVerry BJ; Lawler PR; Angus DC; Annane D; Arabi YM; Aryal D; Au C; Beane A; Berry SM; Berry LR; Best-Lane J; et al. (Journal of thrombosis and haemostasis : JTH, 2026)